Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
6.19
-0.27 (-4.18%)
At close: May 14, 2025, 4:00 PM
6.01
-0.18 (-2.91%)
After-hours: May 14, 2025, 7:21 PM EDT

Trevi Therapeutics Market Cap

Trevi Therapeutics has a market cap or net worth of $629.80 million as of May 14, 2025. Its market cap has increased by 221.64% in one year.

Market Cap
629.80M
Enterprise Value
527.50M
1-Year Change
221.64%
Ranking
Category
Stock Price
$6.19

Market Cap Chart

Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $629.80M, an increase of 641.04%. That is a compound annual growth rate of 39.46%.

History

DateMarket Cap% Change
May 13, 2025656.76M78.38%
Dec 31, 2024368.19M330.28%
Dec 29, 202385.57M-26.01%
Dec 30, 2022115.65M472.04%
Dec 31, 202120.22M-54.55%
Dec 31, 202044.48M-33.49%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 659.45B
Johnson & Johnson 371.06B
UnitedHealth Group 345.29B
AbbVie 326.08B
Novo Nordisk 297.79B
Abbott Laboratories 231.82B
Novartis AG 214.71B
AstraZeneca 211.14B
Market Cap Rankings